Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Bladder tests performed on women before SUI surgery may not be necessary

Invasive and costly tests commonly performed on women before surgery for stress urinary incontinence (SUI) may not be necessary, according to researchers at the University of California San Diego, School of Medicine and the Urinary Incontinence Treatment Network. The study, supported by the National Institutes of Health (NIH), will be released online May 2 by the New England Journal of Medicine.

3 May 2012

Flu paper publication amidst threats of bioterrorism raises need for better rules of censorship

According to the editor of the scientific journal Nature, Dr Philip Campbell current procedures to assess and censor medical research potentially of use to terrorists need to be improved. He was speaking about the recent controversy regarding the bird flu virus H5N1 study. The study was initially stopped from publication fearing risk of bioterrorism. He was speaking to BBC News.

2 May 2012

ImmuVen awarded $1.68M NIH Phase II SBIR grant to develop IMV0123

ImmuVen was awarded a Phase II Small Business Innovation Research (SBIR) grant totaling $1.68 million from the National Institute for Allergy and Infectious Disease (NIH) for continuing development of its therapeutic pipeline (IMV0123) against superantigens produced by methicillin-sensitive and methicillin-resistant Staphylococcal aureus.

2 May 2012

New global strategy to reduce measles deaths and congenital rubella syndrome

Today, the partners leading efforts to control measles announce a new global strategy aimed at reducing measles deaths and congenital rubella syndrome to zero.

2 May 2012

Biogen Idec first quarter revenues increase 7% to $1.3 billion

Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced its first quarter 2012 results.

2 May 2012

Inovio's SynCon vaccine for cervical dysplasias and cancers granted U.S. patent

Inovio Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 8,168,769, covering Inovio's SynCon vaccine for cervical dysplasias and cancers caused by human papillomavirus (HPV).

2 May 2012

Sanofi Pasteur announces new quadrivalent influenza vaccine Phase III pediatric data

Sanofi Pasteur, the vaccines division of Sanofi, announced today new Phase III data for its investigational quadrivalent influenza vaccine (QIV) in children 6 months through 8 years of age.

2 May 2012

FDA approves Protalix, Pfizer’s ELELYSO for treatment of type 1 Gaucher disease

Pfizer Inc. and Protalix BioTherapeutics, Inc. announced today that the United States (U.S.) Food and Drug Administration (FDA) approved ELELYSO (taliglucerase alfa) for injection, an enzyme replacement therapy (ERT) for the long-term treatment of adults with a confirmed diagnosis of type 1 Gaucher disease.

2 May 2012

At-home caregiving comes with personal, financial costs

News outlets examine the costs of care-giving and a new initiative to help Medicaid enrollees stay at home rather than live in nursing homes.

2 May 2012

'Mandatory oversight' of potentially dangerous biological research will be necessary

"In the sobering annals of disaster prevention, genetic manipulation of the H5N1 influenza virus is looming as a seminal case," John Steinbruner, director of the Center for International Security Studies at the University of Maryland, writes in an opinion piece in The Hill's "Congress Blog," noting that two "laboratory experiments have rendered the highly virulent avian strain transmissible among ferrets, strongly suggesting that it would be transmissible among humans as well."

2 May 2012

Anlit Advanced Nutrition Supplements to present new products at Vitafoods Europe 2012

Anlit Advanced Nutrition Supplements, an innovative developer of quality consumer vitamins, minerals and dietary supplements for children, will present new and innovative products at Vitafoods Europe 2012, which will take place May 22-24, 2012 in Geneva, Switzerland.

2 May 2012

Pfizer receives FDA approval for Elelyso to treat Type 1 Gaucher disease

The U.S. Food and Drug Administration today approved Elelyso (taliglucerase alfa) for long-term enzyme replacement therapy to treat a form of Gaucher disease, a rare genetic disorder.

2 May 2012

First Edition: May 1, 2012

Today's health policy headlines include reports from the presidential campaign trail and from states on issues ranging from Massachusetts' payment reform to Idaho's scope-of-practices issues.

2 May 2012

Some public health advocates disagree with Indian government's decision to roll out pentavalent vaccines, IPS reports

"Ignoring widespread concern over the safety, efficacy and cost of pentavalent vaccines" -- which provide protection against diphtheria, pertussis, tetanus, hepatitis B and haemophilus influenza type b (Hib) -- "India's central health ministry has, this month, approved inclusion of the prophylactic cocktail in the universal immunization program in seven of its provinces," Inter Press Service reports.

30 Apr 2012

Dutch government grants export license allowing publication of controversial H5N1 study

"The Dutch government has agreed to grant an export license to allow Ron Fouchier, a virologist at the Erasmus Medical University in Rotterdam, to publish his work on H5N1 avian influenza in Science," Nature's "News Blog" reports (Owens, 4/27). "

30 Apr 2012

Astounding lack of public awareness about lung cancer

An astounding lack of public awareness about lung cancer has been revealed in a Cancer Research UK study, published today.

30 Apr 2012

Milner-Fenwick releases four new ‘Hospital Quality of Care’ videos

Hospitals are under fire. With heightened regulations and guidelines by the federal government and national health care organizations, the pressure to improve patient outcomes has never been greater. In response, the leading publisher of patient education videos, Milner-Fenwick, has released four new videos within its Hospital Quality of Care Series to help facilities comply with growing regulatory requirements. These videos address key hospital issues such as medication safety, infection control, fall prevention and discharge education.

30 Apr 2012

CityBusters battle illness on public transit

The best place to enjoy a breath of fresh air may be a city bus, if Rice University students have their way. A team of graduating seniors has created a system for public transit that would continually clear the air of pathogens that can lead to tuberculosis (TB), flu and pneumonia.

30 Apr 2012

VIVUS receives FDA approval for Stendra to treat erectile dysfunction

The U.S. Food and Drug Administration today approved Stendra (avanafil), a new drug to treat erectile dysfunction.

30 Apr 2012

LifePoint Hospitals first quarter revenues increase 12.2% to $851.0 million

LifePoint Hospitals, Inc. today announced results for the first quarter ended March 31, 2012.

30 Apr 2012

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Bladder tests performed on women before SUI surgery may not be necessary

Flu paper publication amidst threats of bioterrorism raises need for better rules of censorship

ImmuVen awarded $1.68M NIH Phase II SBIR grant to develop IMV0123

New global strategy to reduce measles deaths and congenital rubella syndrome

Biogen Idec first quarter revenues increase 7% to $1.3 billion

Inovio's SynCon vaccine for cervical dysplasias and cancers granted U.S. patent

Sanofi Pasteur announces new quadrivalent influenza vaccine Phase III pediatric data

FDA approves Protalix, Pfizer’s ELELYSO for treatment of type 1 Gaucher disease

At-home caregiving comes with personal, financial costs

'Mandatory oversight' of potentially dangerous biological research will be necessary

Anlit Advanced Nutrition Supplements to present new products at Vitafoods Europe 2012

Pfizer receives FDA approval for Elelyso to treat Type 1 Gaucher disease

First Edition: May 1, 2012

Some public health advocates disagree with Indian government's decision to roll out pentavalent vaccines, IPS reports

Dutch government grants export license allowing publication of controversial H5N1 study

Astounding lack of public awareness about lung cancer

Milner-Fenwick releases four new ‘Hospital Quality of Care’ videos

CityBusters battle illness on public transit

VIVUS receives FDA approval for Stendra to treat erectile dysfunction

LifePoint Hospitals first quarter revenues increase 12.2% to $851.0 million

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in